Roy Musil

Roy Musil

Senior Director Quality at Juno Therapeutics, Inc.

Location:
307 Westlake Ave N Ste 300, Seattle, Washington, United States
HQ Phone:
(206) 582-1600
Wrong Roy Musil?

last updated 2/13/2017

General Information

Experience

Vice President, Quality  - CMC Biologics Inc

Vice President of Quality and Regulatory Affairs  - WINDROSE ANALYTICA INC

Education

Bachelor of Science  - Biochemistry , Concordia University

M.Sc.  - Biochemistry , Concordia University

Affiliations

Executive Director, Quality Control and Quality Assurance  - Althea Technologies , Inc.

Recent News  

Juno Therapeutics | Roy Musil, Sr. Director Quality
Roy Musil Roy Musil Sr. Director Quality | Juno Therapeutics Roy Musil joined Juno Therapeutics in 2014 as the quality site head for their new autologous cellular immunotherapy manufacturing facility. Roy has over 24 years of experience in the fields of recombinant protein and nucleic acid purification, pharmaceutical process development, validation and quality assurance. During his career he has helped build quality systems to support both clinical and commercial manufacturing operations that have enabled numerous successful FDA, DMA and MHRA inspections. Prior to Juno Therapeutics, he served as the Vice President of Quality for CMC Biologics, a leading supplier of global CMO solutions. Roy began his career with the National Research Council of Canada's Biotechnology Institute before moving into industry. He has held positions of increasing responsibility with the Immune Response Corporation SmithKline Beecham (GSK), Althea Technologies, Amgen and Mentor Biologics (JNJ). Mr. Musil holds both a B.Sc. and M.Sc. in Biochemistry from Concordia University (Montreal, Canada).

Read More

Roy Musil, Senior Director Quality | Juno Therapeutics
Roy Musil, Senior Director Quality | Juno Therapeutics Roy Musil, Senior Director Quality | Juno Therapeutics Roy Musil joined Juno Therapeutics in 2014 as the quality site head for their new autologous cellular immunotherapy manufacturing facility. Roy has over 24 years of experience in the fields of recombinant protein and nucleic acid purification, pharmaceutical process development, validation and quality assurance. During his career he has helped build quality systems to support both clinical and commercial manufacturing operations that have enabled numerous successful FDA, DMA and MHRA inspections. Prior to Juno Therapeutics, he served as the Vice President of Quality for CMC Biologics, a leading supplier of global CMO solutions. Roy began his career with the National Research Council of Canada's Biotechnology Institute before moving into industry. He has held positions of increasing responsibility with the Immune Response Corporation SmithKline Beecham (GSK), Althea Technologies, Amgen and Mentor Biologics (JNJ). Mr. Musil holds both a B.Sc. and M.Sc. in Biochemistry from Concordia University (Montreal, Canada).

Read More

Roy Musil - Vice President, Quality
Roy Musil joined CMC Biologics in 2010 as the director of quality assurance, and has since been promoted to Vice President of Quality. He has over 20 years of experience in the fields of recombinant protein and nucleic acid purification, pharmaceutical process development, quality assurance and validation. Prior to CMC Biologics, he was the director of regulatory compliance and quality assurance at Mentor Biologics (JNJ). Roy began his career with the National Research Council of Canada's Biotechnology Institute before moving into industry. Mr. Musil holds both a Bachelor of Science and M.Sc. in Biochemistry from Concordia University (Montreal, Canada).

Read More

Browse ZoomInfo’s Directories